Increase in pre-shock pause caused by drug administration before defibrillation: an observational, full-scale...

Area of Science:

• Emergency Medicine
• Cardiology
• Resuscitation Science

Background:

• Minimizing no-flow time during cardiopulmonary resuscitation (CPR) is crucial for circulation.
• The pre-shock pause, the interval between chest compression cessation and defibrillation, directly impacts defibrillation success.
• The effect of drug administration on the pre-shock pause remains unclear.

Purpose of the Study:

• To compare the pre-shock pause duration with and without concurrent drug administration during a simulated cardiac arrest.
• To evaluate the impact of drug administration timing on resuscitation interruptions.

Main Methods:

• An observational study utilizing full-scale ambulance simulations with 72 junior physicians.
• Video recordings analyzed to identify defibrillation (DC) and drug administration sequences.
• Pre-shock pause calculated for 'Defibrillation only' (DC-only) and 'Drug+DC' sequences.

Main Results:

• Drug administration prior to defibrillation (Drug+DC) significantly increased the median pre-shock pause to 32 seconds compared to 18 seconds for DC-only.
• A statistically significant difference of 8 seconds was observed between median pre-shock pauses (17s DC-only vs. 25s Drug+DC).
• Pre-shock pauses increased by 78% for unpaired and 47% for paired observations when drugs were administered.

Conclusions:

• Drug administration immediately preceding defibrillation is associated with significant increases in pre-shock pause duration.
• These findings suggest that current drug administration protocols may negatively affect defibrillation timing and success.
• Optimizing drug administration timing is essential to minimize interruptions in chest compressions during critical resuscitation events.